These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15046543)

  • 41. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
    Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
    MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treating major depression in children and adolescents: use of selective serotonin reuptake inhibitors needs urgent clarification.
    Herxheimer A
    BMJ; 2004 Feb; 328(7438):525. PubMed ID: 14988211
    [No Abstract]   [Full Text] [Related]  

  • 43. Practitioner review: the pharmacotherapy of adolescent depression.
    Kutcher S
    J Child Psychol Psychiatry; 1997 Oct; 38(7):755-67. PubMed ID: 9363575
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of sertraline in the management of depression.
    Shelton RC
    Clin Ther; 1994; 16(5):768-82; discussion 767. PubMed ID: 7859236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overview of antidepressant therapy.
    Thase ME
    Manag Care; 2001 Aug; 10(8 Suppl):6-9; discussion 18-22. PubMed ID: 11729437
    [No Abstract]   [Full Text] [Related]  

  • 47. Does selectivity matter?
    Deakin JF
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():13-7. PubMed ID: 8732439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The potential benefits of serotonin receptor-specific agents.
    Sussman N
    J Clin Psychiatry; 1994 Feb; 55 Suppl():45-51. PubMed ID: 7521327
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    Westanmo AD; Gayken J; Haight R
    Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. Meta-regression analysis.
    Freemantle N; Anderson IM; Young P
    Br J Psychiatry; 2000 Oct; 177():292-302. PubMed ID: 11116769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dysthymia and serotonin.
    Lapierre YD; Ravindran A; Bakish D
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():87-90. PubMed ID: 8201250
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of antidepressants: why and how they are relevant to treatment.
    Preskorn SH
    J Clin Psychiatry; 1993 Sep; 54 Suppl():14-34; discussion 55-6. PubMed ID: 8407856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treating treatment-resistant depression. Whether to switch, augment, or combine therapies.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Jun; 41(6):14-20. PubMed ID: 12812001
    [No Abstract]   [Full Text] [Related]  

  • 55. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects.
    Stahl SM
    J Clin Psychiatry; 1998; 59 Suppl 18():23-9. PubMed ID: 9840195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modern bioanalytical methods for the rapid detection of antidepressants: SNRIs and SSRIs in human biological samples.
    Samanidou V; Kourti P
    Bioanalysis; 2009 May; 1(2):451-88. PubMed ID: 21083177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of antidepressants on sleep: a review.
    Gursky JT; Krahn LE
    Harv Rev Psychiatry; 2000 Dec; 8(6):298-306. PubMed ID: 11133824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents.
    Dubovsky SL
    J Clin Psychiatry; 1994 Feb; 55 Suppl():34-44. PubMed ID: 8077173
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of new antidepressants.
    Sambunaris A; Hesselink JK; Pinder R; Panagides J; Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 6():40-53. PubMed ID: 9227672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.